Gold Resource Corporation Will Reschedule Release of Its Third Quarter 2023 Results
DENVER--(BUSINESS WIRE)--Gold Resource Corporation (NYSE American: GORO) (the “Companyâ€) announced today that it is postponing…
3 years ago
Apple MixC Wenzhou opens for customers this Saturday, November 4, in China
WENZHOU, China--(BUSINESS WIRE)--Apple® today previewed Apple MixC Wenzhou, the company’s first store in this dynamic…
3 years ago
Singapore’s First Legacy Planning Game Championship to Launch in November
SINGAPORE - Media OutReach - 3 November 2023 - Immortalize, Singapore's most comprehensive elderhood marketplace…
3 years ago
Silvercrest Asset Management Group Inc. Reports Q3 2023 Results
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Silvercrest Asset Management Group Inc. (NASDAQ: SAMG)…
3 years ago
DraftKings Reports Third Quarter Revenue of $790 Million; Raises 2023 Revenue Guidance Midpoint to $3.695 Billion and Improves 2023 Adjusted EBITDA Guidance Midpoint to ($105) Million
Introduces Fiscal Year 2024 Revenue Guidance of $4.5 Billion to $4.8 Billion and Fiscal Year…
3 years ago
High-grade North American Lithium Drill Results Show Potential for Mineral Resource Upgrade
Multiple, new, high-grade lithium zones identified, including outside the planned pit shell model Some intercepts…
3 years ago
Allied Gaming & Entertainment Announces Closing of Strategic Investment to Become Largest Shareholder of Beijing Lianzhong Zhihe Technology Co.
NEW YORK--(BUSINESS WIRE)--Allied Gaming & Entertainment, Inc. (NASDAQ: AGAE) (the “Company†or “AGAEâ€), a global…
3 years ago
Atlassian Announces First Quarter Fiscal Year 2024 Results
Quarterly revenue of $978 million, up 21% year-over-year Quarterly subscription revenue of $852 million, up…
3 years ago
Emory University and Drepung Loseling Celebrate 25 Year Milestone of Original Emory-Tibet Partnership
Inspired by works of His Holiness the Dalai Lama, the collaboration has evolved into a…
3 years ago
New England Journal of Medicine Publishes Complete Results of Positive Phase 2 Trial of Sibeprenlimab in Treatment of Immunoglobulin A Nephropathy (IgAN)
The sibeprenlimab Phase 2 clinical trial results will also be presented this week at the…
3 years ago